1. Home
  2. ZDAI vs RGNT Comparison

ZDAI vs RGNT Comparison

Compare ZDAI & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ZDAI

Primega Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.40

Market Cap

13.5M

ML Signal

N/A

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.64

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZDAI
RGNT
Founded
2022
2004
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
14.3M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
ZDAI
RGNT
Price
$1.40
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.3K
★ 41.6K
Earning Date
08-17-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$1.23
52 Week High
$11.48
$15.50

Technical Indicators

Market Signals
Indicator
ZDAI
RGNT
Relative Strength Index (RSI) 36.10 35.56
Support Level $1.30 $1.23
Resistance Level $1.77 $2.52
Average True Range (ATR) 0.14 0.16
MACD -0.02 -0.03
Stochastic Oscillator 15.45 1.18

Price Performance

Historical Comparison
ZDAI
RGNT

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: